Investor Relations (IR) Questions: International Stem Cell Corp. ISCO
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time ISCO raised cash through an offering (diluted)?
January 2013
2) How much cash (not cash equivalents) does ISCO have?
A little over $2m
3) What and approximately when is the next known catalyst?
Primate study in Parkinson’s disease. Data due before end of 1Q 2013
4) What is ISCO's quarterly cash burn?
Approximately $1.5-1.8MM depending on sales through our commercial businesses
5) Does ISCO have an existing line of credit and if so how much can they draw against it?
Yes. Aspire Capital, $25MM
1) When is the last time ISCO raised cash through an offering (diluted)?
January 2013
2) How much cash (not cash equivalents) does ISCO have?
A little over $2m
3) What and approximately when is the next known catalyst?
Primate study in Parkinson’s disease. Data due before end of 1Q 2013
4) What is ISCO's quarterly cash burn?
Approximately $1.5-1.8MM depending on sales through our commercial businesses
5) Does ISCO have an existing line of credit and if so how much can they draw against it?
Yes. Aspire Capital, $25MM
